use holding simple monolithic solutions says doubts industry embrace right try said congressional hearing bill comment ethical developer experimental medicine know let outside fda regulatory oversight unethical companies find fresh opportunities prey desperate patients new law releases doctors hospitals drugmakers liability stipulates manufacturers charge patients costs provide drug required preapproval charges fda expanded access issues led oppose legislation originally drafted promoted goldwater institute libertarian think tank vibhav rangarajan illinois cardiologist hoped law help year old daughter radha gain access experimental drug rare disease called metachromatic leukodystrophy destroying nervous system wrote movingly plight recent says saddened law lacks meaningful incentives drug